Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. CBD for hypertension. Related story Can CBD Help Your Condition? The results were mixed.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition. Patients can also access CBD products without a prescription through local pharmacies.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines. For more information, visit www.inmedpharma.com.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

Canna Care Docs

OCTOBER 3, 2023

On top of overwhelming struggles or feelings, patients who have been diagnosed with a terminal illness can face a broad range of both physical and psychological effects. Some patients diagnosed with a terminal illness may begin to feel depressed or physically and mentally lethargic from the effects and symptoms of their disease.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

MMJ Recs

NOVEMBER 30, 2023

While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. The two most well-known compounds in cannabis are tetrahydrocannabinol (THC) and cannabidiol (CBD), each of which has distinct effects on the human body.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

MMJ Recs

NOVEMBER 20, 2023

While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). On the other hand, CBD is non-psychoactive and has gained attention for its potential therapeutic applications.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

MMJ Recs

MAY 9, 2024

There are multiple US states with an established state-approved medical marijuana program as well as states permitting the use of cannabinol (CBD) oil – a non-psychoactive component of cannabis – for medical purposes exclusively.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

JUNE 20, 2021

The CIC consists of 97 members dedicated to ensuring a greater understanding of the role of medicinal cannabis, nutraceutical CBD, and hemp across the community and the advancement of medicinal cannabis as an alternate line of therapy. Patient access.

Supply Chain 105

Supply Chain Clinical Trials Research and Development Medicine 105

MMJ Recs

DECEMBER 28, 2023

Strains with a balanced THC and CBD ratio are often recommended for their synergistic effects in pain relief without the intense psychoactive experience. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects. Medical cannabis, with its anxiolytic properties, offers a potential solution.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

FloridaMarijuana.net

AUGUST 15, 2018

Living with PTSD, no matter the underlying cause of the trauma, can be extremely difficult for patients and their loved ones. While PTSD can be treated with therapies and pharmaceutical medications, those are not always successful and additional treatments are necessary.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

MedicalJane

JUNE 29, 2018

On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. The longitudinal study showed that individuals who used artisanal cannabidiol (CBD) products reported better quality of life, lower psychiatric symptom severity and fewer medication-related adverse events compared with those not using CBD.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

TheAnswerPage

FEBRUARY 3, 2020

Is the US VA Office of research and Development conducting any clinical trials that evaluate the use of CBD for the treatment of PTSD? A RCT evaluating the efficacy of using CBD as an adjunctive to prolonged exposure therapy (PE) was started in March 2019 and will conclude on September 30,2023. See Answer.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. So sit back, relax – and if you can’t relax, grab some CBD! What is CBD? Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol.

CBD 99

CBD DEA Research and Development Hemp 99

Veriheal

APRIL 11, 2022

You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Orphan Drug Designation?

DEA 66

DEA Clinical Trials THC Research and Development 66

Miss Marijuana

MAY 13, 2020

Have you ever asked yourself, “How Much CBD should I take?” If so, here’s what a real life cannabis coach has to say about CBD dosage. Cannabidiol (CBD) is flooding the market and everyone seems to be talking about it. Are you curious about trying CBD? How much CBD should you take and how often? Choosing products.

CBD 98

CBD Blood Pressure Clinical Trials Tincture 98

Cannabis Law Report

MAY 10, 2022

This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. However senior author Dr Elizabeth Cairns said the current evidence base for medicinal cannabis for anxiety is limited to only a few studies investigating CBD-dominant products, rather than THC-containing products.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

NOVEMBER 25, 2021

CBD is all the rage, and has been for quite some time. Most cannabis by-products are legal these days, and the CBD industry has been booming. Here are a few reasons why CBD products are more popular than ever this year. However, hope in the form of CBD seems to be on the way. Epilepsy Treatment. Ease Opioid Addiction.

CBD 52

CBD Clinical Trials Epilepsy Chronic Pain 52

Weedistry

MARCH 7, 2019

A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. Guzman administered pure THC via a catheter into the tumors of nine hospitalized patients with glioblastoma, who had failed to respond to standard brain-cancer therapies.

THC 40

THC CBD Clinical Trials Research and Development 40

Healer

MARCH 26, 2021

For years, Tim Gresh took dozens of prescription opioid medications per day, seeking any relief for the debilitating back pain that he – no matter which medication or therapy he used – could just not shake. . “It THC is the main psychoactive compound in marijuana, while CBD is a non-intoxicating cannabinoid found in the cannabis plant.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Otherside Farms

APRIL 30, 2019

CBD oil is an option. Learn more about CBD oil for stress and anxiety here. We’re talking about CBD. We are going to break down how you can use CBD oil for stress and anxiety and some of the incredible research and scientific evidence backing it up. Why Use CBD Oil for Stress or Anxiety? Let’s begin!

Oil 70

Oil CBD Blood Pressure Clinical Trials 70

The Joint Blog

APRIL 22, 2022

Cannabidiol, also popularly known as CBD, is a chemical compound derived from cannabis Sativa plants. However, before consuming CBD in any form, you must seek your doctor’s advice and buy the best CBD oil on the market. Many companies offer CBD oil in multiple forms for general use. Forms of CBD.

Oil 26

Oil CBD Topical Clinical Trials 26

The Joint Blog

JANUARY 31, 2021

According to a new study published in the Journal of Medical Case Reports , the daily use of high-CBD (cannabidiol) marijuana extracts is associated with improvements in the behavioral symptoms related to autism spectrum disorder (ASD). The individual was given very low-doses of marijuana extracts, no larger than 0.2 ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

LifeCannMD

FEBRUARY 1, 2022

As a result, these patients often experience high levels of stress, anxiety, and depression. The symptoms of OCD are often separated into obsession and compulsion, but a patient can be diagnosed for exhibiting severe symptoms in either of these categories: Obsessive. Medical Marijuana for a Patient with OCD. Restlessness.

Marijuana 98

Marijuana Clinical Trials Patients Therapy 98

Cannabis Law Report

MAY 29, 2022

FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. More recently, MDMA therapy has inched closer to FDA approval. Clinical Trials and Human Subject Protections.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

The Herb Collective

JUNE 3, 2018

As Cannabis sales soar around the world, Cannabidiol oil (CBD) is garnering more excitement than the market can stand. Recent clinical studies support its efficacy in burning fat cells, delaying the onset of chronic disease indicators, treating mental health conditions, and killing bacteria.

Oil 56

Oil CBD Blood Pressure Chronic Pain 56

The Cannigma

JUNE 24, 2021

Countless people now use CBD and other hemp-derived products as part of a prescribed medical regimen, as a daily health supplement, or just a go-to panacea to make the stress of daily life a little bit easier to manage. That doesn’t mean that CBD or other cannabis products should be seen as a cure all on their own.

CBD 75

CBD Microdosing Edibles Sleep 75

Miss Marijuana

MAY 13, 2020

Have you ever asked yourself, “How Much CBD should I take?” If so, here’s what a real life cannabis coach has to say about CBD dosage. Cannabidiol (CBD) is flooding the market and everyone seems to be talking about it. Are you curious about trying CBD? How much CBD should you take and how often? Choosing products.

CBD 52

CBD Blood Pressure Clinical Trials Tincture 52

Cannabis Law Report

NOVEMBER 16, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “For 616–623.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Puff Puff Post

OCTOBER 3, 2019

Epidiolex is a CBD-infused oral-based medication designed to help patients as young as two-years-old treat epilepsy disorders. Epidiolex proved tremendously successful in treating epilepsy patients. The possibility of treating the symptoms associated with autism originated when the FDA approved Epidoliolex in 2018.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Cannabis Law Report

JANUARY 5, 2022

This patent issuance is rewarding and timely as we launch our Phase 2 trial of MYMD-1 as a therapy for sarcopenia, frailty, and aging, which is currently recruiting patients,” said Chris Chapman, M.D., MyMD also holds three patents for its synthetic cannabidiol (CBD) derivative Supera-CBD. Unlike other anti-TNF-?

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. These medications are combined in what’s known as HAART (highly active antiretroviral therapy). Cannabis as a palliative aid for HIV patients.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

AUGUST 21, 2019

In November 2018, the legal status of cannabis was changed to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need, following a high-profile media campaign. The final guideline is expected to be published in November 2019.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

DECEMBER 17, 2021

deletion syndrome patient pool and forecasted trend for each seven major countries. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken. deletion syndrome is often underdiagnosed and misdiagnosed, as the symptoms vary from patient to patient. Emerging Drugs.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

The Joint Blog

FEBRUARY 24, 2021

Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s?

Treatment 55

Treatment Clinical Trials Collective Patients 55